Related references
Note: Only part of the references are listed.Seriously Sweet: Acesulfame K Exhibits Selective Inhibition Using Alternative Binding Modes in Carbonic Anhydrase Isoforms
Akilah B. Murray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide
David Bibi et al.
NEUROCHEMICAL RESEARCH (2017)
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors
Claudiu T. Supuran
METABOLITES (2017)
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors
Lorenzo Di Cesare Mannelli et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Thioxocoumarins Show an Alternative Carbonic Anhydrase Inhibition Mechanism Compared to Coumarins
Marta Ferraroni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Benzoxaborole as a new chemotype for carbonic anhydrase inhibition
Vincenzo Alterio et al.
CHEMICAL COMMUNICATIONS (2016)
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium
Francesca Margheri et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Monothiocarbamates Strongly Inhibit Carbonic Anhydrases in Vitro and Possess Intraocular Pressure Lowering Activity in an Animal Model of Glaucoma
Daniela Vullo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune
Daniela Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Acetazolamide for the treatment of idiopathic intracranial hypertension
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Acetazolamide for the treatment of idiopathic intracranial hypertension
Claudiu T. Supuran
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
The η-class carbonic anhydrases as drug targets for antimalarial agents
Claudiu T. Supuran et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors
Jean-Yves Winum et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives
Celeste De Monte et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Secondary and tertiary sulfonamides: a patent review (2008-2012)
Andrea Scozzafava et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)
Simona Maria Monti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Andrea Scozzafava et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005-2013)
Fabrizio Carta et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis
Alfonso Maresca et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Sulfocounnarins (1,2-Benzoxathiine-2,2-dioxides): A Class of Potent and Isoform-Selective Inhibitors of Tumor-Associated Carbonic Anhydrases
Kaspars Tars et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Xanthates and Trithiocarbonates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Effects in Vivo
Fabrizio Carta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors
Anna Di Fiore et al.
CHEMICAL COMMUNICATIONS (2012)
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
Vincenzo Alterio et al.
CHEMICAL REVIEWS (2012)
Novel therapies for glaucoma: a patent review 2007-2011
Fabrizio Carta et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Carbamoylphosphonates Control Tumor Cell Proliferation and Dissemination by Simultaneously Inhibiting Carbonic Anhydrase IX and Matrix Metalloproteinase-2. Toward Nontoxic Chemotherapy Targeting Tumor Microenvironment
Reuven Reich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo
Fabrizio Carta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Carbonic anhydrase inhibitors. Inhibition of the β-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II
Anna Di Fiore et al.
CHEMICAL COMMUNICATIONS (2011)
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
Fabio Pacchiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Carbonic anhydrase inhibitors
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Molecular structure, pKa, lipophilicity, solubility and absorption of biologically active aromatic and heterocyclic sulfonamides
Milan Remko
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM (2010)
Thermodynamic Optimisation in Drug Discovery: A Case Study using Carbonic Anhydrase Inhibitors
Andrew D. Scott et al.
CHEMMEDCHEM (2009)
Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors
Alfonso Maresca et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II
Esra Bayram et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Saccharin inhibits carbonic anhydrases: Possible explanation for its unpleasant metallic aftertaste
Karen Koehler et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Carbonic anhydrase inhibitors.: Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides
S Zimmerman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects
S Pastorekova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties
V Garaj et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors
JY Winum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Share Paper
